Health

People are Choosing Drug Discount Card to Save Money on the Prescribed Drugs

Published

7 years ago

August 19, 2019

A global survey has found that people have been largely going for drug discount card in order to save money on the prescribed drugs. The rising prices of the drugs have contributed to increasing the awareness and hence the demand for drug discount card. With the use of drug discount card, it becomes possible for people to reduce their monthly expenses on drugs. Moreover, the drug sellers also use the drug discount card for their benefit because it helps them to increase their sales and build stronger brand loyalty.

And over the last few years, RX24 drugs has been offering drug coupons to help people cut their drug prices. This entity has not only just been able to make its name in the US but it has also managed to spread the word about its coupon to many other popular nations. According to the survey, about 90% of adults older than 65 believe in taking prescription medicine. 75% of people between 50-64 years go for prescribed drugs. And when it comes to people of age group, 18-29, the percentage of people taking prescribed drugs is 38%. In comparison to the younger people, the number of adults taking prescribed drugs is more. In the US, the demand for drug discount card is increasing among adults for these drug coupons are approved by health organisations such as FDA, HealthCare.gov, and Centers for disease control and prevention (CDC).

About 70% of adults ask for the safety and potential side effects of a new drug on getting prescription from their doctor. Out of the total number of people taking medications, 40% adults ask for a less expensive alternative. The growing demand for drug discount cards is prevalent among the uninsured people who find it difficult to pay for the prescribed drugs due to budget constraints. People of the US and other countries have been supporting drug discount cards as these drug coupon cards help to remove the extra burden of drug prices to some extent. A discount of about 10-20% helps to reduce the drug costs from the shoulders of adult people which is simply making the concept of drug discount cards popular in various corners of the world.

As per the survey details, Americans spend an average of near $900 per year on prescriptions, which is more than other industrialised nations of the world. The reason of the high prices of drugs is simply due to the fact that companies don’t set any limit on the prices of drugs. On inventing a drug, a pharma company gains rights to sell that drug at the price a patient is willing to pay. And there is no facility for bargain on these fixed prices of drugs and hence this is where drug discount programs come handy. These programs only negotiate with the drug stores and skip the companies who make the drugs.

The drug stores accept the offer to sell the drugs at a lower price because they get more business for their stores. All the uninsured people flock to these drug stores in order to buy drugs for them. And it eventually contributes to increasing the brand loyalty of drug stores on a large scale.

Health

BioLongevity Labs: How Two Biohackers Are Making Longevity Safe for the Mainstream

Published

2 weeks ago

February 18, 2026

Michelle Langton

Humans have been looking for ways to extend their lifespan for hundreds of years. Medicine has made impressive strides, but for many, the effects of aging are still painfully real.

Through BioLongevity Labs, biohackers and entrepreneurs Jay Campbell and Josh Felber aim to introduce ordinary people to potentially life-changing compounds called peptides. Campbell and Felber come from very different backgrounds.

Campbell is a five-time international bestselling author and globally recognized leader in the health-optimization space. Felber is a serial entrepreneur who excels at scaling businesses.

For both men, BioLongevity Labs is more than just a business venture — it’s about helping everyday people discover something that just might prolong and improve their lives.

“Your body inevitably changes as the years pile on,” says Campbell. “Your energy drops, and wrinkles start showing up uninvited. Peptides can change everything.”

Many people have probably heard the term “peptide” in passing. Some may know they’re associated with longevity. Most people just don’t have a strong grasp of how they work.

A peptide is a short chain of amino acids, which are the building blocks of proteins. Essentially, peptides are like shorter, simpler proteins. That might sound unremarkable, but the real magic of peptides lies in how they work.

They function as signaling or “messenger” molecules telling the body to perform specific functions. Many peptides function similarly to hormones. A relevant example is GLP-1 (glucagon-like peptide-1) receptor agonists. This class of medications includes semaglutide and tirzepatide, two wildly popular weight-loss drugs.

“These peptides aren’t just another biohacking fad,” Campbell explains. “They enhance insulin secretion and suppress glucagon release to balance blood sugar levels and promote sustainable weight loss”. But what sets GLP-1 receptor agonists apart is their ability to regulate hunger.

Through the reduction of appetite and increased feelings of fullness, it is far easier for dieters to stick to a calorie deficit.” Although GLP-1 receptor agonists are widely prescribed, most peptides aren’t.

Campbell asserts, because many peptides have the potential to cure illnesses by treating the fundamental root cause, they go against America’s “sick care” model of healthcare. They potentially threaten drug companies and their bottom line.

“Peptides are simultaneously a dream come true for mankind and the worst possible nightmare for the pharmaceutical industry,” says Campbell. “It’s not a conspiracy theory. It’s pure economics and psychology in action. People will do whatever it takes to make as much money as possible in a free-market society, even if it means suppressing a superior solution.”

Patients probably aren’t going to be introduced to peptides through the healthcare system. Many discover them on their own. But for the many people who don’t have a solid understanding of how they work molecularly or even what dose to take, there is a risk. That’s precisely what BioLongevity Labs’ co-founders are attempting to address.

Jay Campbell has dedicated his life to educating people about therapeutic peptides and optimized hormones, and along with his partner Josh Felber, they’ve created a company offering filler-free, third-party tested peptides and bioregulators.

Campbell and Felber stress the fact that BioLongevity Labs isn’t meant to be a replacement for traditional medical care. Instead, its products bridge the gap between clinical and extra-clinical care. There’s no magic pill or single solution to solve the problem of aging.

But thanks to the development of specialized peptides, bioregulators, and small molecules, we’re closer than we’ve ever been before.